Pyridinoline cross‐links as markers for primary and secondary bone tumors

REFERENCES

• Engler H, Koeberle D, Thuerlimann B, Sen H-J, Riesen WF. Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease. Clin Chem Lab Med 1998; 36: 879— 85.
   Google Scholar
• Acil Y, Mueller PK. Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline. J Chromatogr A 1994; 644: 183–8.
   Web of Science ®Google Scholar
• Eyre DR, Dickson IR, Van Ness KP. Collagen crosslinking in human bone and cartilage: age-related changes in the content of mature hydroxypyridinium residues. Biochem J 1988; 252: 495–500.
   Google Scholar
• Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984; 137: 380–8.
   Google Scholar
• Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Ann Rev Biochem 1984; 53: 717–48.
   PubMed Web of Science ®Google Scholar
• Robins SP, Seibel MJ, McLaren A. Collagen markers in urine in human arthritis. In: Maroudas A, Kuettner ??, editors. Methods in cartilage research. London: Academic Press, 1990. p. 348–52.
   Google Scholar
• Hata K, Miura M, Fukumoto S, Matsumoto T. Assay of serum pyridinoline: a potential marker for bone resorption. Clin Chimica Acta 1995; 235: 221–7.
   PubMed Web of Science ®Google Scholar
• Seibel MJ, Cosman F, Shen V, Ratcliffe A, Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 881–9.
   Google Scholar
• Seibel MJ, Duncan A, Bobins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16: 964–70.
   Google Scholar
• Robins SP, Duncan A. Pyridinium crosslinks of bone and their location in peptides isolated from rat femur. Biochim Biophys Acta 1987; 914: 233–9.
   PubMed Web of Science ®Google Scholar
• Acil Y, Brinkmann J, Notbohm H, Milner PK, Mtge B. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridi-noline (LP). Scand J Clin Lab Invest 1996; 56: 275— 83.
   PubMed Web of Science ®Google Scholar
• Gerrits MI, Thijssen JHH, Rijn HJM. Determina-tion of pyridinoline and deoxy-pyridinoline in urine, with special attention to retaining their stability. Clin Chem 1995; 41: 571–4.
   Google Scholar
• Maemura M, lino Y, Yokoe T, Takei H. Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in patients with metastatic breast cancer. Oncol Rep 2000; 7: 1333— 8.
   PubMed Web of Science ®Google Scholar
• Garnero P, Shih W, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporo-tic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 6: 1693–700.
   Google Scholar
• Robins SP, Woitge H, Hesley R, Seibel MJ. A direct enzyme linked immunoassay for urinary deoxypyridinoline as a specific marker for measur-ing bone resorption. J Bone Miner Res 1994; 9: 1643–9.
   PubMed Web of Science ®Google Scholar
• Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian J. Urinary hydroxy-pyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992; 74: 481–6.
   PubMed Web of Science ®Google Scholar
• Seibel MJ, Ratcliffe A, Cosman F. Urinary hydroxy-pyridinium crosslinks of collagen are markers of bone resorption and estrogen efficacy in postmenopausal women. Transact Orthop Res Soc 1991; 16: 279.
   Google Scholar
• Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263–70.
   Google Scholar
• Uebelhardt D, Schlemmer A, Johansen J. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocr 1991; 72: 367–73.
   Google Scholar
• Shaarawy M, Hasan M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteporosis. Scand J Clin Lab Invest 2001; 61: 513— 21.
   PubMed Web of Science ®Google Scholar
• Body JJ, Delmas PD. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 1992; 74: 471–5.
   PubMed Web of Science ®Google Scholar
• Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RCF, Ford J. Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer 1992; 65: 766–8.
   Google Scholar
• Demers LM, Costa L, Chinchilli VM, Gaydos L, Curley E, Lipton A. Biochemical markers of bone turnover in patients with metastatic bone disease. Clin Chem 1995; 41: 1489–94.
   PubMed Web of Science ®Google Scholar
• Lipton A, Demers L, Daniloff Y, Curley E, Hamilton Ch, Harvey H, Witters L, Seaman J, Van de Giessen K, Seyedin S. Increased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem 1993; 39: 614–618.
   Google Scholar
• Paterson CR, Robins SP, Horobin JM, Preese PE, Cuschieri A. Pyridinium cross-links as markers of bone resorption in patients with breast cancer. Br J Cancer 1991; 64: 884–6.
   Google Scholar
• Seregni E, Martinetti A, Ferrari L, Bombardieri E. Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumors. Q J Nucl Med 2001; 45: 7–17.
   PubMedGoogle Scholar
• Tamada T, Sone T, Tomomitsu T, Jo Y. Bio-chemical markers for the detection of bone meta-stasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab 2001; 19: 45 — 51.
   PubMed Web of Science ®Google Scholar
• Schachar NS. An update on the nonoperative treatment of patients with metastatic bone disease. Clin Orthop Res 2001; 382: 75–81.
   Google Scholar
• Rauch F, Schönau E, Woitge H, Remer T, Seibel MJ. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol 1994; 102: 94 — 7.
   PubMedGoogle Scholar